Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript November 14, 2023 Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.31. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2023 Earnings Conference Call. As a reminder, this conference is being recorded. […]
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript August 14, 2023 Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $0.23. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call. As a reminder, this conference […]
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call.
Company is well capitalized after signing $50 million working capital credit facility and recent $30 million equity raiseFavorable outcome at Markman hearing in pending CINVANTI® ANDA patent. -Today at 04:06 pm- MarketScreener